Is Senseonics a Winning Diabetes Stock to Own in 2022?

Published on January 14, 2022

Diabetes-focused medical company Senseonics (SENS) reported top- and bottom-line growth in its last reported quarter. But is it wise to bet on the stock now despite the intense competition it...

Continue reading on website
Other news

New Strategies to Cope With Your Supply Chain and Pandemic-Related Disruptions

January 14, 2022
Companies looking to reap consumer loyalty must seriously consider new strategies.

4 Critical Areas of That Add Up to Employee Wellbeing

January 14, 2022
Businesses should deliver more appealing benefits packages so as to increase the retention of current employees.